🇺🇸 FDA
Patent

US 9771414

Human antibodies to ebola virus glycoprotein

granted A61KA61K2039/507A61K39/3955

Quick answer

US patent 9771414 (Human antibodies to ebola virus glycoprotein) held by REGENERON PHARMACEUTICALS, INC. expires Mon Sep 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Sep 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
32
CPC classes
A61K, A61K2039/507, A61K39/3955, A61P, A61P31/14